Atlas Trials

Oral Paclitaxel Plus Fruquintinib Verus Investigator's Choice in Second-Line Advanced Gastric Cancer

Clinical trial NCT07552402 · RECRUITING

Trial details

NCT number
NCT07552402
Sponsor
Harbin Medical University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Start date
2026-06-10
Primary completion
2027-12-30
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.